Skip to main content

Table 2 In-hospital adverse events of the study cohort

From: Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Variables Overall (n = 1401) Patients with thrombocytopenia (n = 186) Patients without thrombocytopenia (n = 1215) p value
In-hospital infection, n (%) 254 (18.1%) 57 (30.6%) 197 (16.2%) < 0.001
Type of infections, n (%)     0.804
 Pulmonary infection 199 (78.3%) 43 (75.4%) 156 (79.2%)  
 Urinary infection 33 (13.0%) 8 (14.0%) 25 (12.7%)  
 Other infections 22 (8.7%) 6 (10.5%) 16 (8.1%)  
MACE, n (%) 255 (18.2%) 56 (30.1%) 199 (16.4%) < 0.001
In-hospital death, n (%) 61 (4.4%) 15 (8.1%) 46 (3.8%) 0.008
Hospital day (d) 8.82 ± 7.40 11.41 ± 10.17 8.43 ± 6.80 < 0.001
  1. Data are presented as mean ± SD or number (percentage)
  2. MACE major adverse clinical events